MyFinsight
Home
Blog
About
Contact
Download
Download image
Share-based compensation
expense
$510,857K
Accrued expenses and
other payables
$311,762K
Net income (loss)
$286,933K
Depreciation and
amortization expense
$141,686K
Proceeds from sale of
future royalties
$911,000K
Proceeds from long-term
loan
$850,586K
Accounts payable
$79,833K
Impairment of equity
investments
$75,626K
Other assets
-$37,164K
Other liabilities
$18,968K
Non-cash interest
expense
$14,872K
Deferred income tax
expense
$9,469K
Deferred revenue
$1,293K
Acquired in-process
research and development
$691K
Loss on long-term
investments
-$596K
Proceeds from short-term
loans
$233,676K
Proceeds from option
exercises and employee...
$196,281K
Net cash provided by
(used in) operating...
$1,127,580K
Net cash provided by
financing activities
$1,059,451K
Canceled cashflow
$362,170K
Effect of foreign
exchange rate changes,...
$60,024K
Canceled cashflow
$1,132,092K
Net increase
(decrease) in cash, cash...
$1,970,900K
Canceled cashflow
$276,155K
Accounts receivable
$164,954K
Amortization of research and
development cost share...
-$101,095K
Inventories
$93,168K
Other items, net
-$2,953K
Repayment of short-term
loans
$1,044,781K
Repayment of long-term
loan
$35,680K
Payments of withholding
taxes from...
$24,195K
Payments of debt issuance
costs
$23,392K
Repayment of sale of future
royalties liability
$4,044K
Proceeds from sale or
maturity of short-term...
$3,446K
Net cash (used in)
provided by investing...
-$276,155K
Canceled cashflow
$3,446K
Purchases of property and
equipment
$185,839K
Purchase of in-process
research and development
$60,691K
Purchase of intangible
assets
$20,000K
Purchase of long-term
investments
$11,834K
Other investing
activities
$1,237K
Back
Back
Cash Flow
source: myfinsight.com
BeOne Medicines Ltd. (ONC)
BeOne Medicines Ltd. (ONC)